FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400536413> ?p ?o ?g. }

• W2400536413 endingPage "5342" @default.
• W2400536413 startingPage "5342" @default.
• W2400536413 abstract "To evaluate the daily high-dose induction therapy with interferon-alpha2b (IFN-alpha2b) in combination with ribavirin for the treatment of patients who failed with interferon monotherapy and had a relapse, based on the assumption that the viral burden would decline faster, thus increasing the likelihood of higher response rates in this difficult-to-treat patient group.Seventy patients were enrolled in this study. Treatment was started with 10 MU IFN-alpha2b daily for 3 wk, followed by IFN-alpha2b 5 MU/TIW in combination with ribavirin (1 000-1 200 mg/d) for 21 wk. In case of a negative HCV RNA PCR, treatment was continued until wk 48 (IFN-alpha2b 3 MU/TIW+1 000-1 200 mg ribavirin/daily).The dose of IFN-alpha2b or ribavirin was reduced in 16% of patients because of hematologic side effects, and treatment was discontinued in 7% of patients. An early viral response (EVR) was achieved in 60% of patients. Fifty percent of all patients achieved an end-of-treatment response (EOT) and 40% obtained a sustained viral response (SVR). Patients with no response had a significantly lower response rate than those with a former relapse (SVR 30% vs 53%; P = 0.049). Furthermore, lower response rates were observed in patients infected with genotype 1a/b than in patients with non-1-genotype (SVR 28% vs 74%; P = 0.001). As a significant predictive factor for a sustained response, a rapid initial decline of HCV RNA could be identified. No patient achieving a negative HCV-RNA PCR at wk 18 or later eventually eliminated the virus.Daily high-dose induction therapy with interferon-alpha2b is well tolerated and effective for the treatment of non-responders and relapsers, when interferon monotherapy fails. A fast decline of viral load during the first 12 wk is strongly associated with a sustained viral response." @default.
• W2400536413 created "2016-06-24" @default.
• W2400536413 creator A5000822169 @default.
• W2400536413 creator A5021475934 @default.
• W2400536413 creator A5043841642 @default.
• W2400536413 creator A5064129630 @default.
• W2400536413 creator A5084279097 @default.
• W2400536413 date "2005-01-01" @default.
• W2400536413 modified "2023-09-27" @default.
• W2400536413 title "High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy" @default.
• W2400536413 cites W1967080996 @default.
• W2400536413 cites W1972599933 @default.
• W2400536413 cites W1995403987 @default.
• W2400536413 cites W2014165835 @default.
• W2400536413 cites W2015292616 @default.
• W2400536413 cites W2018855888 @default.
• W2400536413 cites W2027252289 @default.
• W2400536413 cites W2043519223 @default.
• W2400536413 cites W2046007529 @default.
• W2400536413 cites W2047087932 @default.
• W2400536413 cites W2054586386 @default.
• W2400536413 cites W2079771726 @default.
• W2400536413 cites W2079783845 @default.
• W2400536413 cites W2084732165 @default.
• W2400536413 cites W2105965047 @default.
• W2400536413 cites W2120501783 @default.
• W2400536413 cites W2146192045 @default.
• W2400536413 cites W2165297688 @default.
• W2400536413 cites W2165715544 @default.
• W2400536413 cites W2166971952 @default.
• W2400536413 cites W2317554121 @default.
• W2400536413 cites W2332630894 @default.
• W2400536413 cites W2336799715 @default.
• W2400536413 cites W4237659652 @default.
• W2400536413 cites W57656189 @default.
• W2400536413 doi "https://doi.org/10.3748/wjg.v11.i34.5342" @default.
• W2400536413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4622806" @default.
• W2400536413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16149143" @default.
• W2400536413 hasPublicationYear "2005" @default.
• W2400536413 type Work @default.
• W2400536413 sameAs 2400536413 @default.
• W2400536413 citedByCount "5" @default.
• W2400536413 countsByYear W24005364132013 @default.
• W2400536413 crossrefType "journal-article" @default.
• W2400536413 hasAuthorship W2400536413A5000822169 @default.
• W2400536413 hasAuthorship W2400536413A5021475934 @default.
• W2400536413 hasAuthorship W2400536413A5043841642 @default.
• W2400536413 hasAuthorship W2400536413A5064129630 @default.
• W2400536413 hasAuthorship W2400536413A5084279097 @default.
• W2400536413 hasBestOaLocation W24005364131 @default.
• W2400536413 hasConcept C126322002 @default.
• W2400536413 hasConcept C142462285 @default.
• W2400536413 hasConcept C203014093 @default.
• W2400536413 hasConcept C2522874641 @default.
• W2400536413 hasConcept C2776178377 @default.
• W2400536413 hasConcept C2776455275 @default.
• W2400536413 hasConcept C2776999253 @default.
• W2400536413 hasConcept C2780040827 @default.
• W2400536413 hasConcept C2781228144 @default.
• W2400536413 hasConcept C2909179924 @default.
• W2400536413 hasConcept C3020491458 @default.
• W2400536413 hasConcept C71924100 @default.
• W2400536413 hasConcept C90924648 @default.
• W2400536413 hasConceptScore W2400536413C126322002 @default.
• W2400536413 hasConceptScore W2400536413C142462285 @default.
• W2400536413 hasConceptScore W2400536413C203014093 @default.
• W2400536413 hasConceptScore W2400536413C2522874641 @default.
• W2400536413 hasConceptScore W2400536413C2776178377 @default.
• W2400536413 hasConceptScore W2400536413C2776455275 @default.
• W2400536413 hasConceptScore W2400536413C2776999253 @default.
• W2400536413 hasConceptScore W2400536413C2780040827 @default.
• W2400536413 hasConceptScore W2400536413C2781228144 @default.
• W2400536413 hasConceptScore W2400536413C2909179924 @default.
• W2400536413 hasConceptScore W2400536413C3020491458 @default.
• W2400536413 hasConceptScore W2400536413C71924100 @default.
• W2400536413 hasConceptScore W2400536413C90924648 @default.
• W2400536413 hasIssue "34" @default.
• W2400536413 hasLocation W24005364131 @default.
• W2400536413 hasLocation W24005364132 @default.
• W2400536413 hasLocation W24005364133 @default.
• W2400536413 hasLocation W24005364134 @default.
• W2400536413 hasOpenAccess W2400536413 @default.
• W2400536413 hasPrimaryLocation W24005364131 @default.
• W2400536413 hasRelatedWork W118298973 @default.
• W2400536413 hasRelatedWork W1978167988 @default.
• W2400536413 hasRelatedWork W2076626959 @default.
• W2400536413 hasRelatedWork W2317554121 @default.
• W2400536413 hasRelatedWork W2403634879 @default.
• W2400536413 hasRelatedWork W2418726410 @default.
• W2400536413 hasRelatedWork W2419349742 @default.
• W2400536413 hasRelatedWork W2461318346 @default.
• W2400536413 hasRelatedWork W4256033033 @default.
• W2400536413 hasRelatedWork W48420099 @default.
• W2400536413 hasVolume "11" @default.
• W2400536413 isParatext "false" @default.
• W2400536413 isRetracted "false" @default.
• W2400536413 magId "2400536413" @default.
• W2400536413 workType "article" @default.